Swiss National Bank’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-127,705
| Closed | -$11.9M | – | 2700 |
|
|
2021
Q4 | $11.9M | Buy |
127,705
+400
| +0.3% | +$26.4K | 0.01% | 917 |
|
|
2021
Q3 | $7.58M | Buy |
127,305
+1,000
| +0.8% | +$59.1K | ﹤0.01% | 1158 |
|
|
2021
Q2 | $8.61M | Sell |
126,305
-6,600
| -5% | -$430K | 0.01% | 1107 |
|
|
2021
Q1 | $9.22M | Buy |
132,905
+2,600
| +2% | +$200K | 0.01% | 1052 |
|
|
2020
Q4 | $10M | Buy |
130,305
+4,300
| +3% | +$322K | 0.01% | 927 |
|
|
2020
Q3 | $9.42M | Buy |
126,005
+1,900
| +2% | +$127K | 0.01% | 829 |
|
|
2020
Q2 | $7.81M | Buy |
124,105
+26,875
| +28% | +$1.48M | 0.01% | 900 |
|
|
2020
Q1 | $4.08M | Buy |
97,230
+1,900
| +2% | +$87.1K | ﹤0.01% | 1043 |
|
|
2019
Q4 | $4.33M | Buy |
95,330
+2,000
| +2% | +$94.5K | ﹤0.01% | 1252 |
|
|
2019
Q3 | $4.27M | Buy |
93,330
+1,400
| +2% | +$78.7K | ﹤0.01% | 1191 |
|
|
2019
Q2 | $5.39M | Buy |
91,930
+1,900
| +2% | +$98.2K | 0.01% | 1074 |
|
|
2019
Q1 | $4.04M | Buy |
90,030
+2,800
| +3% | +$128K | ﹤0.01% | 1220 |
|
|
2018
Q4 | $3.4M | Buy |
87,230
+1,400
| +2% | +$55K | ﹤0.01% | 1216 |
|
|
2018
Q3 | $3.95M | Buy |
85,830
+2,200
| +3% | +$89.2K | ﹤0.01% | 1268 |
|
|
2018
Q2 | $3.65M | Hold |
83,630
| – | – | ﹤0.01% | 1306 |
|
|
2018
Q1 | $3.3M | Buy |
83,630
+16,900
| +25% | +$657K | ﹤0.01% | 1310 |
|
|
2017
Q4 | $2.27M | Buy |
66,730
+3,100
| +5% | +$88.3K | ﹤0.01% | 1564 |
|
|
2017
Q3 | $1.62M | Buy |
63,630
+14,800
| +30% | +$339K | ﹤0.01% | 1760 |
|
|
2017
Q2 | $824K | Buy |
48,830
+10,220
| +26% | +$140K | ﹤0.01% | 2172 |
|
|
2017
Q1 | $564K | Hold |
38,610
| – | – | ﹤0.01% | 2338 |
|
|
2016
Q4 | $548K | Hold |
38,610
| – | – | ﹤0.01% | 2351 |
|
|
2016
Q3 | $676K | Hold |
38,610
| – | – | ﹤0.01% | 2203 |
|
|
2016
Q2 | $660K | Hold |
38,610
| – | – | ﹤0.01% | 2201 |
|
|
2016
Q1 | $734K | Buy |
38,610
+7,420
| +24% | +$119K | ﹤0.01% | 2090 |
|
|
2015
Q4 | $593K | Hold |
31,190
| – | – | ﹤0.01% | 2164 |
|
|
2015
Q3 | $596K | Buy |
31,190
+4,110
| +15% | +$140K | ﹤0.01% | 2091 |
|
|
2015
Q2 | $1.26M | Buy |
27,080
+780
| +3% | +$33.8K | ﹤0.01% | 1639 |
|
|
2015
Q1 | $1.15M | Buy |
26,300
+1,820
| +7% | +$84.6K | ﹤0.01% | 1695 |
|
|
2014
Q4 | $849K | Buy |
24,480
+510
| +2% | +$20.7K | ﹤0.01% | 1828 |
|
|
2014
Q3 | $1M | Sell |
23,970
-410
| -2% | -$18.3K | ﹤0.01% | 1664 |
|
|
2014
Q2 | $1.43M | Hold |
24,380
| – | – | 0.01% | 1505 |
|
|
2014
Q1 | $1.54M | Buy |
24,380
+5,570
| +30% | +$370K | 0.01% | 1407 |
|
|
2013
Q4 | $1.1M | Hold |
18,810
| – | – | ﹤0.01% | 1441 |
|
|
2013
Q3 | $991K | Sell |
18,810
-1,010
| -5% | -$67.8K | ﹤0.01% | 1449 |
|
|
2013
Q2 | $1.53M | Buy |
+19,820
| New | +$1.62M | 0.01% | 1148 |
|
Swiss National Bank's ARNA Position: Q1 2022 in Review
Swiss National Bank sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 127,705 shares — an estimated $11.9M sold.
Swiss National Bank first reported a position in ARNA in Q2 2013 and held it in 35 quarters. The position peaked at $11.9M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Swiss National Bank reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Swiss National Bank sold 127,705 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $11.9M.
- Swiss National Bank first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
- Swiss National Bank's Arena Pharmaceuticals Inc position peaked at $11.9M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Swiss National Bank's 13F filing for Q1 2022, filed 9 May 2022.